Categories: News

Healix International opens Vancouver office in response to growing demand for crisis and security risk management services

The new office and growing team will enhance operational capability in the Americas in response to an increasing demand for on the ground, in person support across the world

BOSTON, Jan. 31, 2023 (GLOBE NEWSWIRE) — Healix International, the global provider of security, travel and medical risk management and assistance services, has announced the opening of its new office in Vancouver, British Colombia. The move comes in response to growing demand for its crisis, security, and risk management services.

The opening of the new office comes as Healix expands its operational team in Canada following a surge in demand for its services; a direct result of the turbulence seen throughout 2022. The new office, led by Eilidh Thomson, Regional Security Manager, will offer three distinct services for businesses in the region. These services include intelligence, security advice and assistance and crisis and risk consulting. The focus is to further improve service quality with in-situ regional experts able to assist all clients and prospects within the same time zone, rather than from other base locations in the UK and Singapore.

Vancouver was chosen as the most strategic, practical, and advantageous location for a new office, as it provides access to clients that are already based there, as well as ease of travel to the U.S. The city’s world-class universities also provide a talent pool for recruitment for Healix’s growing team.

Charlie Butcher, CEO at Healix International, commented: “Given the volatility seen in 2022, it’s clear that the services we provide are extremely important to businesses around the world. We already provide support to clients in North America and have teams based in multiple locations across the U.S., but the operational side was always run from the UK, Singapore, South Africa, or New Zealand. Opening the first operational location in the region will mean we can deliver even better services by working with clients more closely on a day-to-day basis. From a business perspective, it also provides a fantastic opportunity to expand further with more services to come later down the line.

“With the opportunity to work with multiple reputable universities and have access to such a wide talent pool, Vancouver was a natural choice and we’re looking forward to seeing the success of the team in 2023.”

About HX Global

HX Global, the U.S. division of Healix International, has been providing assistance and travel risk consultancy solutions to some of the world’s most well-known corporations, governments and NGOs for over two decades. HX Global’s fully integrated team has the skill and experience to address the myriad risks facing today’s travelers. Its combined medical, travel and risk management expertise places HX Global in the unique position to deliver comprehensive, cost-effective solutions without compromising high-quality support for the end-user. To learn more, please visit https://hx-global.com.

CONTACT: For more information
Stephanie Hannon, Vice President, Communications and Brand Strategy, Americas
stephanie.hannon@hx-global.com 
+1 617 750 7907

Staff

Recent Posts

Angle PLC Announces Parsortix and Assays being Showcased at EACR 2024

PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT THE 2024 ANNUAL CONGRESS OF THE EUROPEAN ASSOCIATION…

3 hours ago

Cantargia Strengthen Management Team with The Appointment of Ton Berkien as Chief Business Officer

LUND, SE / ACCESSWIRE / June 11, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq…

3 hours ago

IRLAB Participates in Stora Aktiedagarna

GOTHENBURG, SWEDEN / ACCESSWIRE / June 11, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, June…

3 hours ago

Biden’s DEA Marijuana Scam: MMJ BioPharma Awaits Marijuana Registration to Grow Pharmaceutical Cannabis

NO FEDERAL MARIJUANA IS BEING GROWNMMJ Marijuana Researcher Calls Biden's DEA a Rogue Law Enforcement…

3 hours ago

Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE

SUZHOU, China, and ROCKVILLE, Md., June 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global…

6 hours ago

Element Six and Orbray partner to deliver the world’s highest quality wafer-scale single crystal synthetic diamond

GRESHAM, Ore. and TOKYO , June 10, 2024 /PRNewswire/ -- Element Six (E6) and Orbray, both…

6 hours ago